Your RSA-2048 keys break in 2030. Find every one of them before attackers do.
Not in CISA KEV

CVE-2026-53706

Fix: vbpf/prevail@d3fab8c

CVE-2026-53706 is a CWE-682 vulnerability. O3 Security confirms whether CVE-2026-53706 is actually reachable in your code before you act, and blocks exploitation at runtime until you patch.

PREVAIL is a Polynomial-Runtime EBPF Verifier using an Abstract Interpretation Layer. Prior to version 0.2.4, the prevail eBPF verifier accepts ALU32 ADD and SUB instructions that operate…

Published
Sep 2, 2026
Updated
Sep 2, 2026
Affected
0 pkgs
Patched
None yet
Exploits
None indexed
Exploitation data as of Sep 2, 2026 · OSV.dev, NVD, FIRST.org (EPSS)

Exploitation Status

No confirmed exploitation observed yet

  • CISA assesses this as automatable — exploitation doesn’t require manual, per-target effort, which raises the odds of mass scanning and opportunistic attacks.
  • A successful exploit gives an attacker total control of the affected component, not partial access.
  • CISA’s own triage has not observed active exploitation or public proof-of-concept code for this CVE as of its last assessment.

Exploitation and automatability from CISA’s SSVC triage for CVE-2026-53706.

Description

PREVAIL is a Polynomial-Runtime EBPF Verifier using an Abstract Interpretation Layer. Prior to version 0.2.4, the prevail eBPF verifier accepts ALU32 ADD and SUB instructions that operate on pointer-typed registers without checking the is64 flag. Because ALU32 arithmetic zero-extends the 32-bit result, the upper half of any pointer is silently destroyed at runtime, yet prevail marks the program as verified safe. Any caller that can submit an eBPF program for verification — including unprivileged users on kernels that permit BPF program loading — can produce a program that passes verification but faults or misbehaves at runtime. This issue has been patched in version 0.2.4.

Detection & mitigation playbook

Vulnerability
  1. Detect

    Scan your dependency tree (package-lock.json, pnpm-lock.yaml, requirements.txt, go.sum, etc.) for the affected component. O3's reachability analysis confirms whether the vulnerable code path is actually invoked in your application, so you act on real exposure instead of every transitive match.

  2. Remediation status

    No patched version of the affected component has shipped for CVE-2026-53706 yet. Where your build allows, override or pin the dependency away from the vulnerable range, and apply any maintainer-recommended mitigation.

  3. Mitigate without a patch

    If you can't upgrade right away: gate or disable the affected feature, validate untrusted input at the boundary, and avoid passing attacker-controlled data into the vulnerable path. O3's runtime protection blocks exploitation in production as an interim safeguard until the upgrade lands.

  4. How O3 protects you

    O3 pinpoints whether CVE-2026-53706 is reachable in your code and exactly where to fix it, then blocks exploitation in production at runtime until the patched version is deployed.

Tailored to CVE-2026-53706. Runtime protection reduces exposure until a permanent patch is applied and verified — it complements patching, it doesn't replace it.

Frequently Asked Questions

PREVAIL is a Polynomial-Runtime EBPF Verifier using an Abstract Interpretation Layer. Prior to version 0.2.4, the prevail eBPF verifier accepts ALU32 ADD and SUB instructions that operate on pointer-typed registers without checking the is64 flag. Because ALU32 arithmetic zero-extends the 32-bit result, the upper half of any pointer is silently destroyed at runtime, yet prevail marks the program as verified safe. Any caller that can submit an eBPF program for verification — including unprivileged users on kernels that permit BPF program loading — can produce a program that passes verification b
O3 Security · Impact-Aware SCA

Is CVE-2026-53706 in your dependencies?

O3 detects CVE-2026-53706 across dependencies and uses function-level reachability to confirm whether the vulnerable code path is actually reachable — not just present. No false positives.